5 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
compared the study treatment ... with ‘treatment ... Findings are summarised ... EBM #Management #Pharmacology ... #Personality #Disorder
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... Systemic antifungals are ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
Therapy for Bipolar Disorder ... maintenance agent for treatment ... of bipolar disorder ... #BPD #Toxicity ... #Pharmacology #Psychiatry
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
Alcohol Use Disorder ... - Maintenance Treatment ... Dosing: Goal 150 mg BID ... #Alcohol #Use #Disorder ... #management #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... concentrations are ... Valganciclovir 900 mg PO BID ... Cytomegalovirus #CMV #IDSA ... infections #HIVAIDS #pharmacology